本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Lixte Biotechnology Holdings Inc.

2.83
+0.810040.10%
盘后2.36-0.4700-16.61%16:59 EDT
成交量:6,413.10万
成交额:2.12亿
市值:780.23万
市盈率:-1.96
高:4.25
开:3.02
低:2.44
收:2.02
数据加载中...
2021/03/02

重要事件披露

8-K - Current report
2021/02/03

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/22

重要事件披露

8-K - Current report
2020/12/17

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/17

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/17

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/12/17

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/02

重要事件披露

8-K - Current report
2020/11/27

重要事件披露

8-K - Current report
2020/11/19

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/19

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/16

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/11/16

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/16

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/02

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/10/13

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/09/03

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/08/18

重要事件披露

8-K - Current report